DALYs are a measure of overall disease burden, expressed as the number of years lost due to ill-health, disability or early death.
From a public-health perspective, worrying consequences for overall disease burden arise from these disorders being comorbid.
Overall disease models remain both uncommon and underutilized in addressing the needs for managing molluscan diseases and their host populations.
Overall disease impacts were estimated by the area under the disease progress curve (AUDPC), disease progress rate and disease onset.
In a large meta-analysis by Mauri et al., no significant differences in survival or overall disease progression was observed between patients receiving adjuvant or neoadjuvant chemotherapy [1].
It has been suggested that the severity of forearm deformity correlates with overall disease severity and the risk of malignant degeneration [8].
Treatment is cumbersome and time-consuming, and pruritus can only be addressed insufficiently, mainly by improvements in overall disease control which cannot always be achieved.
DALY is a measure of overall disease burden which is expressed as years lost due to ill-health, disability or death.
We performed the above analyses for individual diseases and for the calculation of overall disease prevalence.
Thus, it remains difficult to predict the overall disease burden that will result from pH1N1.
Overall disease control was therefore 54%.
